Twist Bioscience CorporationTWSTNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank90
3Y CAGR+3.1%
5Y CAGR+10.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+3.1%/yr
vs +27.6%/yr prior
5Y CAGR
+10.5%/yr
Recent deceleration
Acceleration
-24.5pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $336.65M | +2.9% |
| 2025 | $327.26M | -7.6% |
| 2024 | $354.18M | +15.4% |
| 2023 | $306.89M | -3.8% |
| 2022 | $319.01M | +56.0% |
| 2021 | $204.44M | +21.1% |
| 2020 | $168.77M | +45.7% |
| 2019 | $115.81M | +81.5% |
| 2018 | $63.80M | +41.1% |
| 2017 | $45.23M | - |